nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—CYP3A7—Progesterone—uterine cancer	0.0796	0.17	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0796	0.17	CbGbCtD
Risperidone—CYP3A5—Progesterone—uterine cancer	0.0597	0.128	CbGbCtD
Risperidone—ABCB1—Progesterone—uterine cancer	0.0388	0.083	CbGbCtD
Risperidone—CYP2D6—Progesterone—uterine cancer	0.0366	0.0782	CbGbCtD
Risperidone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0351	0.0751	CbGbCtD
Risperidone—ABCB1—Dactinomycin—uterine cancer	0.0308	0.0658	CbGbCtD
Risperidone—CYP3A5—Etoposide—uterine cancer	0.0267	0.0571	CbGbCtD
Risperidone—CYP3A4—Progesterone—uterine cancer	0.0233	0.0497	CbGbCtD
Risperidone—ABCB1—Etoposide—uterine cancer	0.0174	0.0371	CbGbCtD
Risperidone—ABCB1—Doxorubicin—uterine cancer	0.0119	0.0253	CbGbCtD
Risperidone—CYP2D6—Doxorubicin—uterine cancer	0.0112	0.0239	CbGbCtD
Risperidone—CYP3A4—Etoposide—uterine cancer	0.0104	0.0223	CbGbCtD
Risperidone—H1F0—semen—uterine cancer	0.00875	0.086	CbGeAlD
Risperidone—CYP3A4—Doxorubicin—uterine cancer	0.0071	0.0152	CbGbCtD
Risperidone—H1F0—oviduct—uterine cancer	0.00642	0.063	CbGeAlD
Risperidone—HTR1B—artery—uterine cancer	0.0034	0.0334	CbGeAlD
Risperidone—HTR1D—artery—uterine cancer	0.00329	0.0323	CbGeAlD
Risperidone—HTR7—artery—uterine cancer	0.00262	0.0258	CbGeAlD
Risperidone—H1F0—myometrium—uterine cancer	0.00205	0.0202	CbGeAlD
Risperidone—HTR2A—artery—uterine cancer	0.00164	0.0161	CbGeAlD
Risperidone—H1F0—uterine cervix—uterine cancer	0.0016	0.0157	CbGeAlD
Risperidone—ADRA1B—renal system—uterine cancer	0.00158	0.0156	CbGeAlD
Risperidone—H1F0—smooth muscle tissue—uterine cancer	0.00155	0.0153	CbGeAlD
Risperidone—H1F0—decidua—uterine cancer	0.00152	0.015	CbGeAlD
Risperidone—H1F0—renal system—uterine cancer	0.0015	0.0147	CbGeAlD
Risperidone—HTR2B—myometrium—uterine cancer	0.00148	0.0145	CbGeAlD
Risperidone—H1F0—endometrium—uterine cancer	0.00145	0.0142	CbGeAlD
Risperidone—H1F0—mammalian vulva—uterine cancer	0.0014	0.0137	CbGeAlD
Risperidone—H1F0—uterus—uterine cancer	0.00133	0.0131	CbGeAlD
Risperidone—H1F0—female reproductive system—uterine cancer	0.0012	0.0118	CbGeAlD
Risperidone—KCNH2—myometrium—uterine cancer	0.00118	0.0116	CbGeAlD
Risperidone—ADRA2C—myometrium—uterine cancer	0.00116	0.0114	CbGeAlD
Risperidone—HTR2B—uterine cervix—uterine cancer	0.00115	0.0113	CbGeAlD
Risperidone—HTR2B—smooth muscle tissue—uterine cancer	0.00112	0.011	CbGeAlD
Risperidone—HTR2B—decidua—uterine cancer	0.0011	0.0108	CbGeAlD
Risperidone—H1F0—female gonad—uterine cancer	0.00109	0.0107	CbGeAlD
Risperidone—H1F0—vagina—uterine cancer	0.00108	0.0106	CbGeAlD
Risperidone—HTR2B—endometrium—uterine cancer	0.00104	0.0102	CbGeAlD
Risperidone—HTR7—epithelium—uterine cancer	0.000995	0.00977	CbGeAlD
Risperidone—HTR1A—renal system—uterine cancer	0.000965	0.00948	CbGeAlD
Risperidone—HTR2B—uterus—uterine cancer	0.00096	0.00943	CbGeAlD
Risperidone—ADRA1A—epithelium—uterine cancer	0.000959	0.00942	CbGeAlD
Risperidone—HTR7—smooth muscle tissue—uterine cancer	0.000958	0.00941	CbGeAlD
Risperidone—HTR1B—female reproductive system—uterine cancer	0.000958	0.00941	CbGeAlD
Risperidone—HRH1—myometrium—uterine cancer	0.000946	0.00929	CbGeAlD
Risperidone—ADRA2A—myometrium—uterine cancer	0.000929	0.00913	CbGeAlD
Risperidone—HTR1D—female reproductive system—uterine cancer	0.000928	0.00911	CbGeAlD
Risperidone—HTR7—renal system—uterine cancer	0.000923	0.00906	CbGeAlD
Risperidone—KCNH2—uterine cervix—uterine cancer	0.000919	0.00902	CbGeAlD
Risperidone—HTR2C—female reproductive system—uterine cancer	0.000919	0.00902	CbGeAlD
Risperidone—ADRA2C—uterine cervix—uterine cancer	0.000906	0.0089	CbGeAlD
Risperidone—ADRA1A—renal system—uterine cancer	0.00089	0.00874	CbGeAlD
Risperidone—ADRA2C—decidua—uterine cancer	0.000864	0.00848	CbGeAlD
Risperidone—HTR2B—female reproductive system—uterine cancer	0.000863	0.00848	CbGeAlD
Risperidone—KCNH2—renal system—uterine cancer	0.000859	0.00844	CbGeAlD
Risperidone—ADRA2C—renal system—uterine cancer	0.000848	0.00833	CbGeAlD
Risperidone—KCNH2—endometrium—uterine cancer	0.000831	0.00816	CbGeAlD
Risperidone—ADRA2C—endometrium—uterine cancer	0.00082	0.00805	CbGeAlD
Risperidone—ADRA2C—mammalian vulva—uterine cancer	0.000793	0.00779	CbGeAlD
Risperidone—HTR2B—vagina—uterine cancer	0.00078	0.00766	CbGeAlD
Risperidone—KCNH2—uterus—uterine cancer	0.000766	0.00752	CbGeAlD
Risperidone—CYP3A5—uterine cervix—uterine cancer	0.000759	0.00745	CbGeAlD
Risperidone—ADRA2C—uterus—uterine cancer	0.000755	0.00742	CbGeAlD
Risperidone—HRH1—epithelium—uterine cancer	0.000743	0.00729	CbGeAlD
Risperidone—HTR7—female reproductive system—uterine cancer	0.000739	0.00726	CbGeAlD
Risperidone—HRH1—uterine cervix—uterine cancer	0.000736	0.00723	CbGeAlD
Risperidone—ADRA2A—uterine cervix—uterine cancer	0.000723	0.0071	CbGeAlD
Risperidone—HRH1—smooth muscle tissue—uterine cancer	0.000716	0.00703	CbGeAlD
Risperidone—CYP3A5—renal system—uterine cancer	0.00071	0.00697	CbGeAlD
Risperidone—HRH1—decidua—uterine cancer	0.000702	0.00689	CbGeAlD
Risperidone—H1F0—lymph node—uterine cancer	0.0007	0.00688	CbGeAlD
Risperidone—ADRA2A—decidua—uterine cancer	0.000689	0.00677	CbGeAlD
Risperidone—KCNH2—female reproductive system—uterine cancer	0.000688	0.00676	CbGeAlD
Risperidone—HRH1—endometrium—uterine cancer	0.000666	0.00654	CbGeAlD
Risperidone—ADRA2A—endometrium—uterine cancer	0.000654	0.00643	CbGeAlD
Risperidone—HRH1—mammalian vulva—uterine cancer	0.000644	0.00633	CbGeAlD
Risperidone—ADRA2A—mammalian vulva—uterine cancer	0.000633	0.00622	CbGeAlD
Risperidone—KCNH2—female gonad—uterine cancer	0.000626	0.00615	CbGeAlD
Risperidone—KCNH2—vagina—uterine cancer	0.000623	0.00611	CbGeAlD
Risperidone—HTR2A—epithelium—uterine cancer	0.00062	0.00609	CbGeAlD
Risperidone—ADRA2C—female gonad—uterine cancer	0.000618	0.00607	CbGeAlD
Risperidone—ADRA2C—vagina—uterine cancer	0.000614	0.00603	CbGeAlD
Risperidone—ADRA2A—uterus—uterine cancer	0.000603	0.00592	CbGeAlD
Risperidone—HTR2A—smooth muscle tissue—uterine cancer	0.000598	0.00587	CbGeAlD
Risperidone—HTR2A—renal system—uterine cancer	0.000575	0.00565	CbGeAlD
Risperidone—HRH1—female reproductive system—uterine cancer	0.000552	0.00542	CbGeAlD
Risperidone—ADRA2A—female reproductive system—uterine cancer	0.000542	0.00532	CbGeAlD
Risperidone—CYP3A4—renal system—uterine cancer	0.000533	0.00523	CbGeAlD
Risperidone—CYP2D6—renal system—uterine cancer	0.000524	0.00515	CbGeAlD
Risperidone—ABCB1—myometrium—uterine cancer	0.000518	0.00509	CbGeAlD
Risperidone—CYP3A5—female gonad—uterine cancer	0.000517	0.00508	CbGeAlD
Risperidone—CYP3A5—vagina—uterine cancer	0.000514	0.00505	CbGeAlD
Risperidone—HTR2B—lymph node—uterine cancer	0.000505	0.00496	CbGeAlD
Risperidone—HRH1—female gonad—uterine cancer	0.000502	0.00493	CbGeAlD
Risperidone—HRH1—vagina—uterine cancer	0.000499	0.0049	CbGeAlD
Risperidone—ADRA2A—female gonad—uterine cancer	0.000493	0.00484	CbGeAlD
Risperidone—ADRA2A—vagina—uterine cancer	0.00049	0.00481	CbGeAlD
Risperidone—HTR2A—female reproductive system—uterine cancer	0.000461	0.00453	CbGeAlD
Risperidone—CYP3A4—female reproductive system—uterine cancer	0.000427	0.00419	CbGeAlD
Risperidone—CYP2D6—female reproductive system—uterine cancer	0.00042	0.00412	CbGeAlD
Risperidone—HTR2A—vagina—uterine cancer	0.000417	0.00409	CbGeAlD
Risperidone—ABCB1—epithelium—uterine cancer	0.000406	0.00399	CbGeAlD
Risperidone—ABCB1—uterine cervix—uterine cancer	0.000403	0.00396	CbGeAlD
Risperidone—KCNH2—lymph node—uterine cancer	0.000403	0.00395	CbGeAlD
Risperidone—ADRA2C—lymph node—uterine cancer	0.000397	0.0039	CbGeAlD
Risperidone—ABCB1—decidua—uterine cancer	0.000384	0.00377	CbGeAlD
Risperidone—CYP2D6—female gonad—uterine cancer	0.000382	0.00375	CbGeAlD
Risperidone—ABCB1—renal system—uterine cancer	0.000377	0.0037	CbGeAlD
Risperidone—ABCB1—endometrium—uterine cancer	0.000365	0.00358	CbGeAlD
Risperidone—ABCB1—mammalian vulva—uterine cancer	0.000353	0.00346	CbGeAlD
Risperidone—ABCB1—uterus—uterine cancer	0.000336	0.0033	CbGeAlD
Risperidone—HRH1—lymph node—uterine cancer	0.000323	0.00317	CbGeAlD
Risperidone—ADRA2A—lymph node—uterine cancer	0.000317	0.00311	CbGeAlD
Risperidone—ABCB1—female reproductive system—uterine cancer	0.000302	0.00297	CbGeAlD
Risperidone—ABCB1—female gonad—uterine cancer	0.000275	0.0027	CbGeAlD
Risperidone—ABCB1—vagina—uterine cancer	0.000273	0.00268	CbGeAlD
Risperidone—ABCB1—lymph node—uterine cancer	0.000177	0.00173	CbGeAlD
Risperidone—Dyspnoea—Etoposide—uterine cancer	0.000106	0.000265	CcSEcCtD
Risperidone—Hyperglycaemia—Epirubicin—uterine cancer	0.000105	0.000265	CcSEcCtD
Risperidone—Somnolence—Etoposide—uterine cancer	0.000105	0.000265	CcSEcCtD
Risperidone—Angina pectoris—Doxorubicin—uterine cancer	0.000105	0.000264	CcSEcCtD
Risperidone—Pneumonia—Epirubicin—uterine cancer	0.000105	0.000263	CcSEcCtD
Risperidone—Infestation—Epirubicin—uterine cancer	0.000104	0.000261	CcSEcCtD
Risperidone—Infestation NOS—Epirubicin—uterine cancer	0.000104	0.000261	CcSEcCtD
Risperidone—Drowsiness—Epirubicin—uterine cancer	0.000104	0.000261	CcSEcCtD
Risperidone—Vomiting—Dactinomycin—uterine cancer	0.000104	0.000261	CcSEcCtD
Risperidone—Bronchitis—Doxorubicin—uterine cancer	0.000104	0.000261	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000103	0.000259	CcSEcCtD
Risperidone—Rash—Dactinomycin—uterine cancer	0.000103	0.000259	CcSEcCtD
Risperidone—Decreased appetite—Etoposide—uterine cancer	0.000103	0.000259	CcSEcCtD
Risperidone—Renal failure—Epirubicin—uterine cancer	0.000102	0.000257	CcSEcCtD
Risperidone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000102	0.000257	CcSEcCtD
Risperidone—Fatigue—Etoposide—uterine cancer	0.000102	0.000257	CcSEcCtD
Risperidone—Neuropathy peripheral—Epirubicin—uterine cancer	0.000102	0.000256	CcSEcCtD
Risperidone—Jaundice—Epirubicin—uterine cancer	0.000101	0.000255	CcSEcCtD
Risperidone—Stomatitis—Epirubicin—uterine cancer	0.000101	0.000255	CcSEcCtD
Risperidone—Pain—Etoposide—uterine cancer	0.000101	0.000254	CcSEcCtD
Risperidone—Constipation—Etoposide—uterine cancer	0.000101	0.000254	CcSEcCtD
Risperidone—Conjunctivitis—Epirubicin—uterine cancer	0.000101	0.000254	CcSEcCtD
Risperidone—Urinary tract infection—Epirubicin—uterine cancer	0.000101	0.000254	CcSEcCtD
Risperidone—Dysuria—Doxorubicin—uterine cancer	0.000101	0.000254	CcSEcCtD
Risperidone—Neutropenia—Doxorubicin—uterine cancer	0.000101	0.000254	CcSEcCtD
Risperidone—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.0001	0.000252	CcSEcCtD
Risperidone—Sweating—Epirubicin—uterine cancer	9.98e-05	0.000251	CcSEcCtD
Risperidone—Pollakiuria—Doxorubicin—uterine cancer	9.98e-05	0.000251	CcSEcCtD
Risperidone—Haematuria—Epirubicin—uterine cancer	9.92e-05	0.000249	CcSEcCtD
Risperidone—Photosensitivity reaction—Doxorubicin—uterine cancer	9.86e-05	0.000248	CcSEcCtD
Risperidone—Hepatobiliary disease—Epirubicin—uterine cancer	9.84e-05	0.000247	CcSEcCtD
Risperidone—Weight increased—Doxorubicin—uterine cancer	9.83e-05	0.000247	CcSEcCtD
Risperidone—Epistaxis—Epirubicin—uterine cancer	9.82e-05	0.000247	CcSEcCtD
Risperidone—Weight decreased—Doxorubicin—uterine cancer	9.77e-05	0.000246	CcSEcCtD
Risperidone—Sinusitis—Epirubicin—uterine cancer	9.76e-05	0.000245	CcSEcCtD
Risperidone—Feeling abnormal—Etoposide—uterine cancer	9.76e-05	0.000245	CcSEcCtD
Risperidone—Hyperglycaemia—Doxorubicin—uterine cancer	9.74e-05	0.000245	CcSEcCtD
Risperidone—Nausea—Dactinomycin—uterine cancer	9.72e-05	0.000244	CcSEcCtD
Risperidone—Agranulocytosis—Epirubicin—uterine cancer	9.71e-05	0.000244	CcSEcCtD
Risperidone—Pneumonia—Doxorubicin—uterine cancer	9.69e-05	0.000243	CcSEcCtD
Risperidone—Gastrointestinal pain—Etoposide—uterine cancer	9.68e-05	0.000243	CcSEcCtD
Risperidone—Drowsiness—Doxorubicin—uterine cancer	9.63e-05	0.000242	CcSEcCtD
Risperidone—Infestation—Doxorubicin—uterine cancer	9.63e-05	0.000242	CcSEcCtD
Risperidone—Infestation NOS—Doxorubicin—uterine cancer	9.63e-05	0.000242	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	9.55e-05	0.00024	CcSEcCtD
Risperidone—Bradycardia—Epirubicin—uterine cancer	9.51e-05	0.000239	CcSEcCtD
Risperidone—Renal failure—Doxorubicin—uterine cancer	9.47e-05	0.000238	CcSEcCtD
Risperidone—Neuropathy peripheral—Doxorubicin—uterine cancer	9.44e-05	0.000237	CcSEcCtD
Risperidone—Urticaria—Etoposide—uterine cancer	9.41e-05	0.000236	CcSEcCtD
Risperidone—Haemoglobin—Epirubicin—uterine cancer	9.39e-05	0.000236	CcSEcCtD
Risperidone—Stomatitis—Doxorubicin—uterine cancer	9.39e-05	0.000236	CcSEcCtD
Risperidone—Jaundice—Doxorubicin—uterine cancer	9.39e-05	0.000236	CcSEcCtD
Risperidone—Rhinitis—Epirubicin—uterine cancer	9.37e-05	0.000235	CcSEcCtD
Risperidone—Body temperature increased—Etoposide—uterine cancer	9.36e-05	0.000235	CcSEcCtD
Risperidone—Abdominal pain—Etoposide—uterine cancer	9.36e-05	0.000235	CcSEcCtD
Risperidone—Conjunctivitis—Doxorubicin—uterine cancer	9.36e-05	0.000235	CcSEcCtD
Risperidone—Urinary tract infection—Doxorubicin—uterine cancer	9.36e-05	0.000235	CcSEcCtD
Risperidone—Haemorrhage—Epirubicin—uterine cancer	9.34e-05	0.000235	CcSEcCtD
Risperidone—Hepatitis—Epirubicin—uterine cancer	9.34e-05	0.000235	CcSEcCtD
Risperidone—Hypoaesthesia—Epirubicin—uterine cancer	9.3e-05	0.000234	CcSEcCtD
Risperidone—Pharyngitis—Epirubicin—uterine cancer	9.27e-05	0.000233	CcSEcCtD
Risperidone—Sweating—Doxorubicin—uterine cancer	9.23e-05	0.000232	CcSEcCtD
Risperidone—Urinary tract disorder—Epirubicin—uterine cancer	9.23e-05	0.000232	CcSEcCtD
Risperidone—Oedema peripheral—Epirubicin—uterine cancer	9.2e-05	0.000231	CcSEcCtD
Risperidone—Haematuria—Doxorubicin—uterine cancer	9.18e-05	0.000231	CcSEcCtD
Risperidone—Connective tissue disorder—Epirubicin—uterine cancer	9.18e-05	0.000231	CcSEcCtD
Risperidone—Urethral disorder—Epirubicin—uterine cancer	9.16e-05	0.00023	CcSEcCtD
Risperidone—Hepatobiliary disease—Doxorubicin—uterine cancer	9.11e-05	0.000229	CcSEcCtD
Risperidone—Epistaxis—Doxorubicin—uterine cancer	9.08e-05	0.000228	CcSEcCtD
Risperidone—Sinusitis—Doxorubicin—uterine cancer	9.03e-05	0.000227	CcSEcCtD
Risperidone—Visual impairment—Epirubicin—uterine cancer	9e-05	0.000226	CcSEcCtD
Risperidone—Agranulocytosis—Doxorubicin—uterine cancer	8.99e-05	0.000226	CcSEcCtD
Risperidone—Erythema multiforme—Epirubicin—uterine cancer	8.83e-05	0.000222	CcSEcCtD
Risperidone—Bradycardia—Doxorubicin—uterine cancer	8.8e-05	0.000221	CcSEcCtD
Risperidone—Eye disorder—Epirubicin—uterine cancer	8.73e-05	0.000219	CcSEcCtD
Risperidone—Hypersensitivity—Etoposide—uterine cancer	8.72e-05	0.000219	CcSEcCtD
Risperidone—Tinnitus—Epirubicin—uterine cancer	8.71e-05	0.000219	CcSEcCtD
Risperidone—Haemoglobin—Doxorubicin—uterine cancer	8.69e-05	0.000218	CcSEcCtD
Risperidone—Flushing—Epirubicin—uterine cancer	8.67e-05	0.000218	CcSEcCtD
Risperidone—Cardiac disorder—Epirubicin—uterine cancer	8.67e-05	0.000218	CcSEcCtD
Risperidone—Rhinitis—Doxorubicin—uterine cancer	8.67e-05	0.000218	CcSEcCtD
Risperidone—Haemorrhage—Doxorubicin—uterine cancer	8.64e-05	0.000217	CcSEcCtD
Risperidone—Hepatitis—Doxorubicin—uterine cancer	8.64e-05	0.000217	CcSEcCtD
Risperidone—Hypoaesthesia—Doxorubicin—uterine cancer	8.6e-05	0.000216	CcSEcCtD
Risperidone—Pharyngitis—Doxorubicin—uterine cancer	8.58e-05	0.000216	CcSEcCtD
Risperidone—Urinary tract disorder—Doxorubicin—uterine cancer	8.54e-05	0.000215	CcSEcCtD
Risperidone—Oedema peripheral—Doxorubicin—uterine cancer	8.52e-05	0.000214	CcSEcCtD
Risperidone—Asthenia—Etoposide—uterine cancer	8.5e-05	0.000213	CcSEcCtD
Risperidone—Connective tissue disorder—Doxorubicin—uterine cancer	8.49e-05	0.000213	CcSEcCtD
Risperidone—Angiopathy—Epirubicin—uterine cancer	8.48e-05	0.000213	CcSEcCtD
Risperidone—Urethral disorder—Doxorubicin—uterine cancer	8.47e-05	0.000213	CcSEcCtD
Risperidone—Immune system disorder—Epirubicin—uterine cancer	8.44e-05	0.000212	CcSEcCtD
Risperidone—Mediastinal disorder—Epirubicin—uterine cancer	8.42e-05	0.000212	CcSEcCtD
Risperidone—Chills—Epirubicin—uterine cancer	8.38e-05	0.000211	CcSEcCtD
Risperidone—Pruritus—Etoposide—uterine cancer	8.38e-05	0.00021	CcSEcCtD
Risperidone—Arrhythmia—Epirubicin—uterine cancer	8.35e-05	0.00021	CcSEcCtD
Risperidone—Visual impairment—Doxorubicin—uterine cancer	8.33e-05	0.000209	CcSEcCtD
Risperidone—Alopecia—Epirubicin—uterine cancer	8.26e-05	0.000207	CcSEcCtD
Risperidone—Mental disorder—Epirubicin—uterine cancer	8.19e-05	0.000206	CcSEcCtD
Risperidone—Erythema multiforme—Doxorubicin—uterine cancer	8.17e-05	0.000205	CcSEcCtD
Risperidone—Erythema—Epirubicin—uterine cancer	8.13e-05	0.000204	CcSEcCtD
Risperidone—Malnutrition—Epirubicin—uterine cancer	8.13e-05	0.000204	CcSEcCtD
Risperidone—Diarrhoea—Etoposide—uterine cancer	8.1e-05	0.000204	CcSEcCtD
Risperidone—Eye disorder—Doxorubicin—uterine cancer	8.08e-05	0.000203	CcSEcCtD
Risperidone—Tinnitus—Doxorubicin—uterine cancer	8.06e-05	0.000203	CcSEcCtD
Risperidone—Cardiac disorder—Doxorubicin—uterine cancer	8.02e-05	0.000202	CcSEcCtD
Risperidone—Flushing—Doxorubicin—uterine cancer	8.02e-05	0.000202	CcSEcCtD
Risperidone—Flatulence—Epirubicin—uterine cancer	8.01e-05	0.000201	CcSEcCtD
Risperidone—Tension—Epirubicin—uterine cancer	7.98e-05	0.000201	CcSEcCtD
Risperidone—Dysgeusia—Epirubicin—uterine cancer	7.96e-05	0.0002	CcSEcCtD
Risperidone—Nervousness—Epirubicin—uterine cancer	7.9e-05	0.000198	CcSEcCtD
Risperidone—Back pain—Epirubicin—uterine cancer	7.87e-05	0.000198	CcSEcCtD
Risperidone—Angiopathy—Doxorubicin—uterine cancer	7.84e-05	0.000197	CcSEcCtD
Risperidone—Dizziness—Etoposide—uterine cancer	7.83e-05	0.000197	CcSEcCtD
Risperidone—Muscle spasms—Epirubicin—uterine cancer	7.82e-05	0.000196	CcSEcCtD
Risperidone—Immune system disorder—Doxorubicin—uterine cancer	7.81e-05	0.000196	CcSEcCtD
Risperidone—Mediastinal disorder—Doxorubicin—uterine cancer	7.79e-05	0.000196	CcSEcCtD
Risperidone—Chills—Doxorubicin—uterine cancer	7.76e-05	0.000195	CcSEcCtD
Risperidone—Arrhythmia—Doxorubicin—uterine cancer	7.72e-05	0.000194	CcSEcCtD
Risperidone—Vision blurred—Epirubicin—uterine cancer	7.66e-05	0.000193	CcSEcCtD
Risperidone—Alopecia—Doxorubicin—uterine cancer	7.64e-05	0.000192	CcSEcCtD
Risperidone—Mental disorder—Doxorubicin—uterine cancer	7.57e-05	0.00019	CcSEcCtD
Risperidone—Ill-defined disorder—Epirubicin—uterine cancer	7.55e-05	0.00019	CcSEcCtD
Risperidone—Vomiting—Etoposide—uterine cancer	7.53e-05	0.000189	CcSEcCtD
Risperidone—Erythema—Doxorubicin—uterine cancer	7.53e-05	0.000189	CcSEcCtD
Risperidone—Malnutrition—Doxorubicin—uterine cancer	7.53e-05	0.000189	CcSEcCtD
Risperidone—Anaemia—Epirubicin—uterine cancer	7.52e-05	0.000189	CcSEcCtD
Risperidone—Agitation—Epirubicin—uterine cancer	7.47e-05	0.000188	CcSEcCtD
Risperidone—Rash—Etoposide—uterine cancer	7.47e-05	0.000188	CcSEcCtD
Risperidone—Dermatitis—Etoposide—uterine cancer	7.46e-05	0.000187	CcSEcCtD
Risperidone—Headache—Etoposide—uterine cancer	7.42e-05	0.000186	CcSEcCtD
Risperidone—Flatulence—Doxorubicin—uterine cancer	7.42e-05	0.000186	CcSEcCtD
Risperidone—Tension—Doxorubicin—uterine cancer	7.38e-05	0.000186	CcSEcCtD
Risperidone—Dysgeusia—Doxorubicin—uterine cancer	7.37e-05	0.000185	CcSEcCtD
Risperidone—Malaise—Epirubicin—uterine cancer	7.33e-05	0.000184	CcSEcCtD
Risperidone—Nervousness—Doxorubicin—uterine cancer	7.31e-05	0.000184	CcSEcCtD
Risperidone—Vertigo—Epirubicin—uterine cancer	7.31e-05	0.000184	CcSEcCtD
Risperidone—Syncope—Epirubicin—uterine cancer	7.29e-05	0.000183	CcSEcCtD
Risperidone—Leukopenia—Epirubicin—uterine cancer	7.28e-05	0.000183	CcSEcCtD
Risperidone—Back pain—Doxorubicin—uterine cancer	7.28e-05	0.000183	CcSEcCtD
Risperidone—Muscle spasms—Doxorubicin—uterine cancer	7.23e-05	0.000182	CcSEcCtD
Risperidone—Palpitations—Epirubicin—uterine cancer	7.19e-05	0.000181	CcSEcCtD
Risperidone—Loss of consciousness—Epirubicin—uterine cancer	7.15e-05	0.00018	CcSEcCtD
Risperidone—Cough—Epirubicin—uterine cancer	7.1e-05	0.000178	CcSEcCtD
Risperidone—Vision blurred—Doxorubicin—uterine cancer	7.09e-05	0.000178	CcSEcCtD
Risperidone—Convulsion—Epirubicin—uterine cancer	7.05e-05	0.000177	CcSEcCtD
Risperidone—Nausea—Etoposide—uterine cancer	7.03e-05	0.000177	CcSEcCtD
Risperidone—Hypertension—Epirubicin—uterine cancer	7.02e-05	0.000176	CcSEcCtD
Risperidone—Ill-defined disorder—Doxorubicin—uterine cancer	6.98e-05	0.000175	CcSEcCtD
Risperidone—Anaemia—Doxorubicin—uterine cancer	6.96e-05	0.000175	CcSEcCtD
Risperidone—Arthralgia—Epirubicin—uterine cancer	6.92e-05	0.000174	CcSEcCtD
Risperidone—Myalgia—Epirubicin—uterine cancer	6.92e-05	0.000174	CcSEcCtD
Risperidone—Chest pain—Epirubicin—uterine cancer	6.92e-05	0.000174	CcSEcCtD
Risperidone—Agitation—Doxorubicin—uterine cancer	6.92e-05	0.000174	CcSEcCtD
Risperidone—Anxiety—Epirubicin—uterine cancer	6.9e-05	0.000173	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	6.88e-05	0.000173	CcSEcCtD
Risperidone—Discomfort—Epirubicin—uterine cancer	6.84e-05	0.000172	CcSEcCtD
Risperidone—Malaise—Doxorubicin—uterine cancer	6.79e-05	0.000171	CcSEcCtD
Risperidone—Dry mouth—Epirubicin—uterine cancer	6.77e-05	0.00017	CcSEcCtD
Risperidone—Vertigo—Doxorubicin—uterine cancer	6.76e-05	0.00017	CcSEcCtD
Risperidone—Syncope—Doxorubicin—uterine cancer	6.75e-05	0.00017	CcSEcCtD
Risperidone—Leukopenia—Doxorubicin—uterine cancer	6.74e-05	0.000169	CcSEcCtD
Risperidone—Confusional state—Epirubicin—uterine cancer	6.69e-05	0.000168	CcSEcCtD
Risperidone—Palpitations—Doxorubicin—uterine cancer	6.65e-05	0.000167	CcSEcCtD
Risperidone—Oedema—Epirubicin—uterine cancer	6.64e-05	0.000167	CcSEcCtD
Risperidone—Anaphylactic shock—Epirubicin—uterine cancer	6.64e-05	0.000167	CcSEcCtD
Risperidone—Loss of consciousness—Doxorubicin—uterine cancer	6.61e-05	0.000166	CcSEcCtD
Risperidone—Infection—Epirubicin—uterine cancer	6.59e-05	0.000166	CcSEcCtD
Risperidone—Cough—Doxorubicin—uterine cancer	6.57e-05	0.000165	CcSEcCtD
Risperidone—Shock—Epirubicin—uterine cancer	6.53e-05	0.000164	CcSEcCtD
Risperidone—Convulsion—Doxorubicin—uterine cancer	6.52e-05	0.000164	CcSEcCtD
Risperidone—Nervous system disorder—Epirubicin—uterine cancer	6.51e-05	0.000164	CcSEcCtD
Risperidone—Thrombocytopenia—Epirubicin—uterine cancer	6.5e-05	0.000163	CcSEcCtD
Risperidone—Hypertension—Doxorubicin—uterine cancer	6.5e-05	0.000163	CcSEcCtD
Risperidone—Tachycardia—Epirubicin—uterine cancer	6.48e-05	0.000163	CcSEcCtD
Risperidone—Skin disorder—Epirubicin—uterine cancer	6.45e-05	0.000162	CcSEcCtD
Risperidone—Hyperhidrosis—Epirubicin—uterine cancer	6.42e-05	0.000161	CcSEcCtD
Risperidone—Myalgia—Doxorubicin—uterine cancer	6.41e-05	0.000161	CcSEcCtD
Risperidone—Chest pain—Doxorubicin—uterine cancer	6.41e-05	0.000161	CcSEcCtD
Risperidone—Arthralgia—Doxorubicin—uterine cancer	6.41e-05	0.000161	CcSEcCtD
Risperidone—Anxiety—Doxorubicin—uterine cancer	6.38e-05	0.00016	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	6.36e-05	0.00016	CcSEcCtD
Risperidone—Discomfort—Doxorubicin—uterine cancer	6.33e-05	0.000159	CcSEcCtD
Risperidone—Anorexia—Epirubicin—uterine cancer	6.33e-05	0.000159	CcSEcCtD
Risperidone—Dry mouth—Doxorubicin—uterine cancer	6.27e-05	0.000157	CcSEcCtD
Risperidone—Hypotension—Epirubicin—uterine cancer	6.2e-05	0.000156	CcSEcCtD
Risperidone—Confusional state—Doxorubicin—uterine cancer	6.19e-05	0.000156	CcSEcCtD
Risperidone—Oedema—Doxorubicin—uterine cancer	6.14e-05	0.000154	CcSEcCtD
Risperidone—Anaphylactic shock—Doxorubicin—uterine cancer	6.14e-05	0.000154	CcSEcCtD
Risperidone—Infection—Doxorubicin—uterine cancer	6.1e-05	0.000153	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.05e-05	0.000152	CcSEcCtD
Risperidone—Shock—Doxorubicin—uterine cancer	6.04e-05	0.000152	CcSEcCtD
Risperidone—Nervous system disorder—Doxorubicin—uterine cancer	6.02e-05	0.000151	CcSEcCtD
Risperidone—Thrombocytopenia—Doxorubicin—uterine cancer	6.01e-05	0.000151	CcSEcCtD
Risperidone—Insomnia—Epirubicin—uterine cancer	6e-05	0.000151	CcSEcCtD
Risperidone—Tachycardia—Doxorubicin—uterine cancer	5.99e-05	0.000151	CcSEcCtD
Risperidone—Skin disorder—Doxorubicin—uterine cancer	5.97e-05	0.00015	CcSEcCtD
Risperidone—Paraesthesia—Epirubicin—uterine cancer	5.96e-05	0.00015	CcSEcCtD
Risperidone—Hyperhidrosis—Doxorubicin—uterine cancer	5.94e-05	0.000149	CcSEcCtD
Risperidone—Dyspnoea—Epirubicin—uterine cancer	5.92e-05	0.000149	CcSEcCtD
Risperidone—Somnolence—Epirubicin—uterine cancer	5.9e-05	0.000148	CcSEcCtD
Risperidone—Anorexia—Doxorubicin—uterine cancer	5.85e-05	0.000147	CcSEcCtD
Risperidone—Dyspepsia—Epirubicin—uterine cancer	5.84e-05	0.000147	CcSEcCtD
Risperidone—Decreased appetite—Epirubicin—uterine cancer	5.77e-05	0.000145	CcSEcCtD
Risperidone—Hypotension—Doxorubicin—uterine cancer	5.74e-05	0.000144	CcSEcCtD
Risperidone—Gastrointestinal disorder—Epirubicin—uterine cancer	5.73e-05	0.000144	CcSEcCtD
Risperidone—Fatigue—Epirubicin—uterine cancer	5.72e-05	0.000144	CcSEcCtD
Risperidone—Pain—Epirubicin—uterine cancer	5.68e-05	0.000143	CcSEcCtD
Risperidone—Constipation—Epirubicin—uterine cancer	5.68e-05	0.000143	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.6e-05	0.000141	CcSEcCtD
Risperidone—Insomnia—Doxorubicin—uterine cancer	5.55e-05	0.00014	CcSEcCtD
Risperidone—Paraesthesia—Doxorubicin—uterine cancer	5.51e-05	0.000139	CcSEcCtD
Risperidone—Dyspnoea—Doxorubicin—uterine cancer	5.48e-05	0.000138	CcSEcCtD
Risperidone—Feeling abnormal—Epirubicin—uterine cancer	5.47e-05	0.000137	CcSEcCtD
Risperidone—Somnolence—Doxorubicin—uterine cancer	5.46e-05	0.000137	CcSEcCtD
Risperidone—Gastrointestinal pain—Epirubicin—uterine cancer	5.43e-05	0.000136	CcSEcCtD
Risperidone—Dyspepsia—Doxorubicin—uterine cancer	5.41e-05	0.000136	CcSEcCtD
Risperidone—Decreased appetite—Doxorubicin—uterine cancer	5.34e-05	0.000134	CcSEcCtD
Risperidone—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.3e-05	0.000133	CcSEcCtD
Risperidone—Fatigue—Doxorubicin—uterine cancer	5.3e-05	0.000133	CcSEcCtD
Risperidone—Urticaria—Epirubicin—uterine cancer	5.27e-05	0.000132	CcSEcCtD
Risperidone—Pain—Doxorubicin—uterine cancer	5.25e-05	0.000132	CcSEcCtD
Risperidone—Constipation—Doxorubicin—uterine cancer	5.25e-05	0.000132	CcSEcCtD
Risperidone—Abdominal pain—Epirubicin—uterine cancer	5.25e-05	0.000132	CcSEcCtD
Risperidone—Body temperature increased—Epirubicin—uterine cancer	5.25e-05	0.000132	CcSEcCtD
Risperidone—Feeling abnormal—Doxorubicin—uterine cancer	5.06e-05	0.000127	CcSEcCtD
Risperidone—Gastrointestinal pain—Doxorubicin—uterine cancer	5.02e-05	0.000126	CcSEcCtD
Risperidone—Hypersensitivity—Epirubicin—uterine cancer	4.89e-05	0.000123	CcSEcCtD
Risperidone—Urticaria—Doxorubicin—uterine cancer	4.88e-05	0.000123	CcSEcCtD
Risperidone—Body temperature increased—Doxorubicin—uterine cancer	4.86e-05	0.000122	CcSEcCtD
Risperidone—Abdominal pain—Doxorubicin—uterine cancer	4.86e-05	0.000122	CcSEcCtD
Risperidone—Asthenia—Epirubicin—uterine cancer	4.76e-05	0.00012	CcSEcCtD
Risperidone—Pruritus—Epirubicin—uterine cancer	4.7e-05	0.000118	CcSEcCtD
Risperidone—Diarrhoea—Epirubicin—uterine cancer	4.54e-05	0.000114	CcSEcCtD
Risperidone—Hypersensitivity—Doxorubicin—uterine cancer	4.52e-05	0.000114	CcSEcCtD
Risperidone—Asthenia—Doxorubicin—uterine cancer	4.41e-05	0.000111	CcSEcCtD
Risperidone—Dizziness—Epirubicin—uterine cancer	4.39e-05	0.00011	CcSEcCtD
Risperidone—Pruritus—Doxorubicin—uterine cancer	4.35e-05	0.000109	CcSEcCtD
Risperidone—Vomiting—Epirubicin—uterine cancer	4.22e-05	0.000106	CcSEcCtD
Risperidone—Diarrhoea—Doxorubicin—uterine cancer	4.2e-05	0.000106	CcSEcCtD
Risperidone—Rash—Epirubicin—uterine cancer	4.19e-05	0.000105	CcSEcCtD
Risperidone—Dermatitis—Epirubicin—uterine cancer	4.18e-05	0.000105	CcSEcCtD
Risperidone—Headache—Epirubicin—uterine cancer	4.16e-05	0.000104	CcSEcCtD
Risperidone—Dizziness—Doxorubicin—uterine cancer	4.06e-05	0.000102	CcSEcCtD
Risperidone—Nausea—Epirubicin—uterine cancer	3.94e-05	9.91e-05	CcSEcCtD
Risperidone—Vomiting—Doxorubicin—uterine cancer	3.9e-05	9.81e-05	CcSEcCtD
Risperidone—Rash—Doxorubicin—uterine cancer	3.87e-05	9.73e-05	CcSEcCtD
Risperidone—Dermatitis—Doxorubicin—uterine cancer	3.87e-05	9.72e-05	CcSEcCtD
Risperidone—Headache—Doxorubicin—uterine cancer	3.85e-05	9.67e-05	CcSEcCtD
Risperidone—Nausea—Doxorubicin—uterine cancer	3.65e-05	9.17e-05	CcSEcCtD
Risperidone—DRD4—Signaling Pathways—NRAS—uterine cancer	4.89e-06	0.000152	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CXCL8—uterine cancer	4.89e-06	0.000152	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PTEN—uterine cancer	4.87e-06	0.000152	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—HRAS—uterine cancer	4.86e-06	0.000151	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—KRAS—uterine cancer	4.84e-06	0.000151	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—PIK3CA—uterine cancer	4.83e-06	0.00015	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—EP300—uterine cancer	4.82e-06	0.00015	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—PIK3CA—uterine cancer	4.82e-06	0.00015	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ERBB2—uterine cancer	4.81e-06	0.00015	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—AKT1—uterine cancer	4.81e-06	0.00015	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	4.81e-06	0.00015	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CDKN1B—uterine cancer	4.77e-06	0.000149	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—KRAS—uterine cancer	4.76e-06	0.000149	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—KRAS—uterine cancer	4.75e-06	0.000148	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—AKT1—uterine cancer	4.75e-06	0.000148	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ERBB2—uterine cancer	4.74e-06	0.000148	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—VEGFA—uterine cancer	4.73e-06	0.000147	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—AKT1—uterine cancer	4.72e-06	0.000147	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—PIK3CA—uterine cancer	4.72e-06	0.000147	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CXCL8—uterine cancer	4.72e-06	0.000147	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EP300—uterine cancer	4.71e-06	0.000147	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CXCL8—uterine cancer	4.69e-06	0.000146	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCL2—uterine cancer	4.69e-06	0.000146	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—HRAS—uterine cancer	4.69e-06	0.000146	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—EP300—uterine cancer	4.68e-06	0.000146	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—MTHFR—uterine cancer	4.67e-06	0.000146	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—NRAS—uterine cancer	4.67e-06	0.000146	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—KRAS—uterine cancer	4.67e-06	0.000145	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—HRAS—uterine cancer	4.66e-06	0.000145	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EP300—uterine cancer	4.64e-06	0.000145	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CDKN1B—uterine cancer	4.61e-06	0.000144	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CDKN1B—uterine cancer	4.58e-06	0.000143	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CXCL8—uterine cancer	4.57e-06	0.000142	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—AKT1—uterine cancer	4.56e-06	0.000142	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—HRAS—uterine cancer	4.54e-06	0.000141	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	4.53e-06	0.000141	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CTNNB1—uterine cancer	4.51e-06	0.000141	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CXCL8—uterine cancer	4.49e-06	0.00014	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—HRAS—uterine cancer	4.46e-06	0.000139	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CDKN1B—uterine cancer	4.46e-06	0.000139	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—uterine cancer	4.46e-06	0.000139	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	4.45e-06	0.000139	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—AKT1—uterine cancer	4.41e-06	0.000138	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NRAS—uterine cancer	4.4e-06	0.000137	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—uterine cancer	4.4e-06	0.000137	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—KRAS—uterine cancer	4.4e-06	0.000137	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PTEN—uterine cancer	4.4e-06	0.000137	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CDKN1B—uterine cancer	4.39e-06	0.000137	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	4.39e-06	0.000137	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	4.38e-06	0.000137	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ERBB2—uterine cancer	4.37e-06	0.000136	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	4.37e-06	0.000136	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—KRAS—uterine cancer	4.37e-06	0.000136	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CTNNB1—uterine cancer	4.35e-06	0.000136	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NRAS—uterine cancer	4.34e-06	0.000135	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—AKT1—uterine cancer	4.34e-06	0.000135	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	4.33e-06	0.000135	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	4.33e-06	0.000135	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ERBB2—uterine cancer	4.3e-06	0.000134	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ERBB2—uterine cancer	4.29e-06	0.000134	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—AKT1—uterine cancer	4.29e-06	0.000134	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	4.29e-06	0.000134	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—KRAS—uterine cancer	4.28e-06	0.000133	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PTEN—uterine cancer	4.24e-06	0.000132	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PTEN—uterine cancer	4.22e-06	0.000132	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CTNNB1—uterine cancer	4.21e-06	0.000131	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	4.21e-06	0.000131	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—KRAS—uterine cancer	4.21e-06	0.000131	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EP300—uterine cancer	4.19e-06	0.000131	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CTNNB1—uterine cancer	4.15e-06	0.000129	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CXCL8—uterine cancer	4.14e-06	0.000129	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—AKT1—uterine cancer	4.14e-06	0.000129	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—AKT1—uterine cancer	4.12e-06	0.000128	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—HRAS—uterine cancer	4.12e-06	0.000128	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PTEN—uterine cancer	4.11e-06	0.000128	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CXCL8—uterine cancer	4.08e-06	0.000127	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CXCL8—uterine cancer	4.07e-06	0.000127	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—STK11—uterine cancer	4.06e-06	0.000127	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.06e-06	0.000127	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—HRAS—uterine cancer	4.05e-06	0.000126	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EP300—uterine cancer	4.05e-06	0.000126	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CDKN1B—uterine cancer	4.05e-06	0.000126	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—HRAS—uterine cancer	4.04e-06	0.000126	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PTEN—uterine cancer	4.04e-06	0.000126	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—PIK3CA—uterine cancer	4.04e-06	0.000126	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EP300—uterine cancer	4.03e-06	0.000126	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—KRAS—uterine cancer	4.02e-06	0.000125	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—PIK3CA—uterine cancer	4.01e-06	0.000125	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—AKT1—uterine cancer	4.01e-06	0.000125	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—AKT1—uterine cancer	4e-06	0.000125	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	3.99e-06	0.000124	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTEN—uterine cancer	3.99e-06	0.000124	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	3.98e-06	0.000124	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	3.98e-06	0.000124	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CDKN1B—uterine cancer	3.97e-06	0.000124	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—uterine cancer	3.97e-06	0.000124	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	3.97e-06	0.000124	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	3.94e-06	0.000123	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	3.94e-06	0.000123	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AKT1—uterine cancer	3.93e-06	0.000123	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PIK3CA—uterine cancer	3.93e-06	0.000123	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NRAS—uterine cancer	3.92e-06	0.000122	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EP300—uterine cancer	3.92e-06	0.000122	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	3.91e-06	0.000122	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—uterine cancer	3.91e-06	0.000122	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	3.9e-06	0.000122	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—uterine cancer	3.88e-06	0.000121	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PIK3CA—uterine cancer	3.87e-06	0.000121	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	3.86e-06	0.00012	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EP300—uterine cancer	3.85e-06	0.00012	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—uterine cancer	3.83e-06	0.00012	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CTNNB1—uterine cancer	3.82e-06	0.000119	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—uterine cancer	3.81e-06	0.000119	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—EP300—uterine cancer	3.8e-06	0.000119	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—uterine cancer	3.8e-06	0.000119	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—KRAS—uterine cancer	3.79e-06	0.000118	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NRAS—uterine cancer	3.79e-06	0.000118	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NRAS—uterine cancer	3.77e-06	0.000117	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	3.76e-06	0.000117	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CTNNB1—uterine cancer	3.75e-06	0.000117	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—uterine cancer	3.74e-06	0.000117	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—KRAS—uterine cancer	3.74e-06	0.000117	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—HRAS—uterine cancer	3.74e-06	0.000117	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PTEN—uterine cancer	3.73e-06	0.000116	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—HRAS—uterine cancer	3.71e-06	0.000116	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	3.71e-06	0.000116	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—uterine cancer	3.71e-06	0.000116	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PIK3CA—uterine cancer	3.69e-06	0.000115	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	3.68e-06	0.000115	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	3.68e-06	0.000115	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PTEN—uterine cancer	3.67e-06	0.000114	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NRAS—uterine cancer	3.66e-06	0.000114	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PTEN—uterine cancer	3.66e-06	0.000114	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTEN—uterine cancer	3.65e-06	0.000114	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	3.65e-06	0.000114	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—HRAS—uterine cancer	3.64e-06	0.000113	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—uterine cancer	3.63e-06	0.000113	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	3.62e-06	0.000113	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NRAS—uterine cancer	3.61e-06	0.000112	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PTEN—uterine cancer	3.59e-06	0.000112	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	3.58e-06	0.000112	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HRAS—uterine cancer	3.58e-06	0.000112	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—uterine cancer	3.58e-06	0.000112	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—uterine cancer	3.57e-06	0.000111	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—uterine cancer	3.57e-06	0.000111	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PIK3CA—uterine cancer	3.57e-06	0.000111	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EP300—uterine cancer	3.55e-06	0.000111	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	3.5e-06	0.000109	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EP300—uterine cancer	3.5e-06	0.000109	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EP300—uterine cancer	3.49e-06	0.000109	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—EP300—uterine cancer	3.49e-06	0.000109	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PIK3CA—uterine cancer	3.48e-06	0.000109	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PIK3CA—uterine cancer	3.46e-06	0.000108	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PIK3CA—uterine cancer	3.43e-06	0.000107	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EP300—uterine cancer	3.42e-06	0.000107	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	3.42e-06	0.000107	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HRAS—uterine cancer	3.42e-06	0.000106	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—KRAS—uterine cancer	3.38e-06	0.000105	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—uterine cancer	3.37e-06	0.000105	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—uterine cancer	3.36e-06	0.000105	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PTEN—uterine cancer	3.33e-06	0.000104	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NRAS—uterine cancer	3.32e-06	0.000104	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—uterine cancer	3.32e-06	0.000104	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—uterine cancer	3.31e-06	0.000103	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—uterine cancer	3.3e-06	0.000103	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—uterine cancer	3.3e-06	0.000103	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—uterine cancer	3.28e-06	0.000102	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NRAS—uterine cancer	3.27e-06	0.000102	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NRAS—uterine cancer	3.26e-06	0.000102	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—KRAS—uterine cancer	3.26e-06	0.000102	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	3.25e-06	0.000101	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	3.24e-06	0.000101	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—KRAS—uterine cancer	3.24e-06	0.000101	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HRAS—uterine cancer	3.22e-06	0.0001	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—uterine cancer	3.21e-06	0.0001	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NRAS—uterine cancer	3.2e-06	9.99e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EP300—uterine cancer	3.18e-06	9.92e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HRAS—uterine cancer	3.18e-06	9.91e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—uterine cancer	3.16e-06	9.85e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—KRAS—uterine cancer	3.15e-06	9.83e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—KRAS—uterine cancer	3.1e-06	9.68e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PIK3CA—uterine cancer	3.1e-06	9.67e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MTHFR—uterine cancer	3.05e-06	9.52e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—uterine cancer	3.02e-06	9.4e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	3.01e-06	9.39e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—uterine cancer	3e-06	9.35e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	2.99e-06	9.33e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	2.98e-06	9.29e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NRAS—uterine cancer	2.98e-06	9.28e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—uterine cancer	2.91e-06	9.09e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PIK3CA—uterine cancer	2.9e-06	9.03e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—uterine cancer	2.9e-06	9.03e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—uterine cancer	2.88e-06	8.98e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HRAS—uterine cancer	2.87e-06	8.95e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—KRAS—uterine cancer	2.86e-06	8.92e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	2.85e-06	8.89e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—uterine cancer	2.84e-06	8.87e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—uterine cancer	2.83e-06	8.82e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—KRAS—uterine cancer	2.81e-06	8.78e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PIK3CA—uterine cancer	2.81e-06	8.77e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KRAS—uterine cancer	2.81e-06	8.76e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—uterine cancer	2.81e-06	8.75e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—uterine cancer	2.8e-06	8.74e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HRAS—uterine cancer	2.77e-06	8.64e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTEN—uterine cancer	2.76e-06	8.6e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—uterine cancer	2.76e-06	8.6e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KRAS—uterine cancer	2.76e-06	8.59e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HRAS—uterine cancer	2.76e-06	8.59e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HRAS—uterine cancer	2.68e-06	8.36e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HRAS—uterine cancer	2.64e-06	8.22e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—EP300—uterine cancer	2.63e-06	8.2e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CA—uterine cancer	2.63e-06	8.2e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTEN—uterine cancer	2.6e-06	8.1e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	2.59e-06	8.06e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CA—uterine cancer	2.58e-06	8.05e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.58e-06	8.04e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KRAS—uterine cancer	2.56e-06	7.99e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—uterine cancer	2.54e-06	7.93e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—uterine cancer	2.53e-06	7.9e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	2.53e-06	7.9e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—uterine cancer	2.5e-06	7.8e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—uterine cancer	2.5e-06	7.78e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—EP300—uterine cancer	2.48e-06	7.73e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—uterine cancer	2.45e-06	7.64e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—uterine cancer	2.45e-06	7.63e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—uterine cancer	2.43e-06	7.59e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HRAS—uterine cancer	2.43e-06	7.58e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HRAS—uterine cancer	2.39e-06	7.46e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HRAS—uterine cancer	2.39e-06	7.44e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—uterine cancer	2.37e-06	7.38e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	2.35e-06	7.34e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HRAS—uterine cancer	2.34e-06	7.31e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—uterine cancer	2.33e-06	7.26e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—uterine cancer	2.3e-06	7.17e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—uterine cancer	2.28e-06	7.1e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HRAS—uterine cancer	2.18e-06	6.79e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—uterine cancer	2.15e-06	6.69e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—uterine cancer	2.11e-06	6.59e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—uterine cancer	2.11e-06	6.57e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—uterine cancer	2.11e-06	6.57e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—uterine cancer	2.07e-06	6.45e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CA—uterine cancer	1.95e-06	6.07e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—uterine cancer	1.92e-06	5.99e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.83e-06	5.72e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTEN—uterine cancer	1.7e-06	5.3e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—EP300—uterine cancer	1.62e-06	5.05e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—uterine cancer	1.59e-06	4.96e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—uterine cancer	1.5e-06	4.67e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.2e-06	3.74e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—uterine cancer	9.79e-07	3.05e-05	CbGpPWpGaD
